Related Experiment Video
Updated: Feb 9, 2026

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
What is the role of PCSK9 inhibitors in treating hypercholesterolemia?
1Mark Volpe practices at Suffield (Conn.) Medical Associates, New England Urgent Care in Enfield, Conn., and Priority Urgent Care in Ellington, Conn. He is a guest lecturer in the University of St. Joseph PA program in West Hartford, Conn., and a clinical preceptor for students in the PA program at Yale University in New Haven, Conn. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
PCSK9 inhibitors are a novel medical therapy for treating hypercholesterolemia. This article reviews the basic properties of PCSK9 inhibitors, including their mechanism of action, indications, contraindications, adverse reactions, and efficacy.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Dipeptidyl Peptidase 4 Inhibitors
Role-Based Identity
Role of Hippocampus in Memory

